Literature DB >> 15153726

Association between mast cells and bladder carcinoma.

T Ahmet Serel1, Sedat Soyupek, Ozden Candir.   

Abstract

INTRODUCTION: The aim of this study was to determine whether there are quantitative variations in the numbers of mast cells (MCs) in bladder carcinoma tissue associated with the histopathological grading of tumours.
MATERIALS AND METHODS: Specimens of 56 bladder carcinomas were stained with toluidine blue and histologically staged using the Mostofi system. The MC counts were assessed within tumour tissue and lamina propria of the bladder. The MCs in the adjacent 'normal bladder tissue' of 14 specimens from patients who underwent cystectomy and of 10 specimens from patients having interstitial cystitis were also determined. The results were analyzed by using the Student t test, the Wilcoxon signed-rank test, and the Spearman correlation (r(s)).
RESULTS: The mean MC concentration was 0.57 within the tumour tissue and 3.36 in the lamina propria. The difference between the two MC groups was statistically significant (p < 0.0001); there were no correlations between mean MC counts in tumour tissue and histopathological tumour grade and between mean MC counts in lamina propria and histopathological tumour grade. Statistically significant differences were also observed between tumour group and interstitial cystitis group (p = 0.029) and between tumour group and normal 'adjacent' tissue group (p = 0.037).
CONCLUSIONS: Our findings suggest that MCs aggregate in small numbers in the lamina propria of bladder carcinomas and that the MC count is related to tumour differentiation. The number of MCs may be a useful prognostic indicator in patients with bladder carcinoma. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 15153726     DOI: 10.1159/000077681

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  7 in total

1.  Metabolite marker discovery for the detection of bladder cancer by comparative metabolomics.

Authors:  Chi-Hung Shao; Chien-Lun Chen; Jia-You Lin; Chao-Jung Chen; Shu-Hsuan Fu; Yi-Ting Chen; Yu-Sun Chang; Jau-Song Yu; Ke-Hung Tsui; Chiun-Gung Juo; Kun-Pin Wu
Journal:  Oncotarget       Date:  2017-06-13

2.  Bacillus Calmette-Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer.

Authors:  Fei Su; Ming Liu; Wei Zhang; Min Tang; Jinsong Zhang; Hexin Li; Lihui Zou; Rui Zhang; Yudong Liu; Lin Li; Jie Ma; Yaqun Zhang; Meng Chen; Fei Xiao
Journal:  Front Oncol       Date:  2022-03-03       Impact factor: 6.244

3.  Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERβ/CCL2/CCR2 EMT/MMP9 signals.

Authors:  Qun Rao; Yuan Chen; Chiuan-Ren Yeh; Jie Ding; Lei Li; Chawnshang Chang; Shuyuan Yeh
Journal:  Oncotarget       Date:  2016-02-16

4.  Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals.

Authors:  Chiuan-Ren Yeh; Zheng-Yu Ou; Guang-Qian Xiao; Elizabeth Guancial; Shuyuan Yeh
Journal:  Oncotarget       Date:  2015-12-29

Review 5.  Inflammatory microenvironment in the initiation and progression of bladder cancer.

Authors:  Xinbing Sui; Liming Lei; Liuxi Chen; Tian Xie; Xue Li
Journal:  Oncotarget       Date:  2017-10-06

6.  Metabolomic profiling identifies novel biomarkers and mechanisms in human bladder cancer treated with submucosal injection of gemcitabine.

Authors:  Chao Yang; Xian Sun; Hengbing Wang; Ting Lu; Keqing Wu; Yusheng Guan; Jing Tang; Jian Liang; Rongli Sun; Zhongying Guo; Sinian Zheng; Xiaoli Wu; Hesong Jiang; Xi Jiang; Bing Zhong; Xiaobing Niu; Suan Sun; Xinru Wang; Minjian Chen; Guangbo Fu
Journal:  Int J Mol Med       Date:  2019-09-23       Impact factor: 4.101

7.  Survey of Mast Cell Density in Transitional Cell Carcinoma.

Authors:  Hedieh Moradi Tabriz; Maedeh Obohat; Farzan Vahedifard; Arezoo Eftekharjavadi
Journal:  Iran J Pathol       Date:  2020-12-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.